Claire Henchcliffe, MD
Enriched profileStanley van den Noort Professor and Chair, Department of Neurology · University of California, Irvine School of Medicine
Claire Henchcliffe is Stanley van den Noort Professor and Chair, Department of Neurology at University of California, Irvine School of Medicine. OpenAlex indexes 133 publications with 6,024 citations (h-index 38); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Claire Henchcliffe, MD, PHD, is Stanley van den Noort Professor and Chair, Department of Neurology at University of California, Irvine School of Medicine. The public record shows 133 publications with 6,024 citations (h-index 38), centered on Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Dementia and Cognitive Impairment Research. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 8 companies.
- Most recent indexed publication: 2026 · Neural regeneration research
- Top research focus: Parkinson's Disease Mechanisms and Treatments
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 63.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers
Sponsor: Weill Medical College of Cornell University
- Fox Investigation for New Discovery of Biomarkers
Sponsor: Michael J. Fox Foundation for Parkinson's Research
- Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy
Sponsor: Weill Medical College of Cornell University
Industry payments
Updated 16 Oct 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20251 payment
- TOLMAR, INC.Program year20251 payment
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20242 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Aromatic Amino Acid Decarboxylation Inhibitor72.7%Carbidopa-Levodopa61%Rytary25%Carbidopa-Levodopa Er15%Part D<11 patientsCholinesterase Inhibitor13.7%Donepezil Hcl51%Rivastigmine49%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Advances and unmet needs in fluid and tissue biomarkers in Parkinson's disease.
Neural regeneration research
Article2026 - When colony-stimulating factor 1 receptor (CSF1R) breaks the mold.
Developmental medicine and child neurology
Article2026 - Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape.
Journal of Parkinson's disease
Review2026
Most-cited works
by citation count (OpenAlex)- 01Mitochondrial biology and oxidative stress in Parkinson disease pathogenesisArticle785 citations2008
- 02Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s DiseaseArticle537 citations2020
- 03A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson DiseaseArticle409 citations2014
- 04The future of stem cell therapies for Parkinson diseaseReview307 citations2020
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/claire-henchcliffe-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Other
synapse.mskcc.org/synapse/people/19477
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →synapse.mskcc.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Columbia University College of Physicians and Surgeons
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.uci.edu ↗ - DPhil in Molecular and Cell Biology
University of Oxford
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.uci.edu ↗
Editorial & leadership roles
journal and society appointments- Fellow
American Neurological Association (FANA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →2026.myana.org ↗ - Fellow
American Academy of Neurology (FAAN)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →2025.myana.org ↗
Media & interviews
press, podcasts and appearances- Podcast guest
Physician Huddle by UCI Health: From gene therapy to focused ultrasound: Advancing the future of neurological care
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinicalconnection.ucihealth.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida